Dasman Diabetes Institute   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Sharq Kuwait (2006)

Organization Overview

First Clinical Trial
2013
NCT01980459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dasman Diabetes Institute | Dasman Diabetes Institute. Ministry of Health, Kuwait | Dasmin Diabetes Institute | Nadia Zghoul, PhD, Dept of Clinical Research | Senior diabetes educator in Dasman Diabetes Institute

Active Ingredients

Drugs in Phase 4 Trials (1)

pioglitazone (actos) (1 trial)

Drugs in Phase 2 Trials (2)

aphoelinebrake (1 trial)

hmaxi-k (1 trial)

Drugs in Phase 1 Trials (1)

magnesium lactate (1 trial)

Drugs in Other Trials (2)

krill oil (1 trial)

vegetable oil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Erectile Dysfunction (Phase 2)

Inflammation (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 6